NASDAQ:SMLR - Nasdaq - US81684M1045 - Common Stock - Currency: USD
41.88
-1.39 (-3.21%)
The current stock price of SMLR is 41.88 USD. In the past month the price increased by 25.84%. In the past year, price increased by 79.59%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.28 | 234.48B | ||
ISRG | INTUITIVE SURGICAL INC | 72.93 | 199.70B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.46 | 157.58B | ||
SYK | STRYKER CORP | 31.09 | 148.69B | ||
MDT | MEDTRONIC PLC | 16.17 | 110.77B | ||
BDX | BECTON DICKINSON AND CO | 12.54 | 50.73B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.93 | 45.76B | ||
IDXX | IDEXX LABORATORIES INC | 45.36 | 41.91B | ||
RMD | RESMED INC | 27.33 | 36.38B | ||
DXCM | DEXCOM INC | 52.93 | 34.25B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.62 | 32.90B | ||
STE | STERIS PLC | 26.82 | 24.61B |
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
SEMLER SCIENTIFIC INC
2340-2348 Walsh Avenue, Suite 2344
Santa Clara CALIFORNIA 97210 US
CEO: Douglas Murphy-Chutorian
Employees: 79
Phone: 14086274557
The current stock price of SMLR is 41.88 USD. The price decreased by -3.21% in the last trading session.
The exchange symbol of SEMLER SCIENTIFIC INC is SMLR and it is listed on the Nasdaq exchange.
SMLR stock is listed on the Nasdaq exchange.
7 analysts have analysed SMLR and the average price target is 72.42 USD. This implies a price increase of 72.92% is expected in the next year compared to the current price of 41.88. Check the SEMLER SCIENTIFIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SEMLER SCIENTIFIC INC (SMLR) has a market capitalization of 506.33M USD. This makes SMLR a Small Cap stock.
SEMLER SCIENTIFIC INC (SMLR) currently has 79 employees.
SEMLER SCIENTIFIC INC (SMLR) has a support level at 34.01 and a resistance level at 41.89. Check the full technical report for a detailed analysis of SMLR support and resistance levels.
The Revenue of SEMLER SCIENTIFIC INC (SMLR) is expected to grow by 1.07% in the next year. Check the estimates tab for more information on the SMLR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SMLR does not pay a dividend.
SEMLER SCIENTIFIC INC (SMLR) will report earnings on 2025-08-04.
The PE ratio for SEMLER SCIENTIFIC INC (SMLR) is 10.44. This is based on the reported non-GAAP earnings per share of 4.01 and the current share price of 41.88 USD. Check the full fundamental report for a full analysis of the valuation metrics for SMLR.
The outstanding short interest for SEMLER SCIENTIFIC INC (SMLR) is 16.49% of its float. Check the ownership tab for more information on the SMLR short interest.
ChartMill assigns a technical rating of 6 / 10 to SMLR. When comparing the yearly performance of all stocks, SMLR is one of the better performing stocks in the market, outperforming 93.23% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to SMLR. Both the health and profitability get an excellent rating, making SMLR a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months SMLR reported a non-GAAP Earnings per Share(EPS) of 4.01. The EPS increased by 38.28% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 72.65% | ||
ROA | 17.05% | ||
ROE | 17.72% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to SMLR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -67.65% and a revenue growth 1.07% for SMLR